CoChat

Up‐regulation of miR‐210 by vascular endothelial growth factor in ex vivo expanded CD 34+ cells enhances cell‐mediated angiogenesis

Open access
Alaiti, Mohamad Amer, Ishikawa, Masakazu, Masuda, Haruchika, Simon, Daniel I., Jain, Mukesh K., Asahara, Takayuki, Costa, Marco A. · 2012 · Journal of Cellular and Molecular Medicine
Cited by 76

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Ex vivo culture has been proposed as a means to augment and repair autologous cells in patients with chronic diseases, but the mechanisms governing improvement in cell function are not well understood. Although micro RNA s (miRs) are increasingly appreciated as key regulators of cellular function, a role for these factors in CD 34+ cell‐mediated angiogenesis has not been elucidated. Vascular endothelial growth factor (VEGF) was previously shown to induce expression of certain miRs associated with angiogenesis in endothelial cells and promote survival and number of vascular colony forming units of haematopoietic stem cells (HSC s). We sought to evaluate the role of VEGF in expansion and angiogenic function of CD 34+ cells and to identify specific miRs associated with angiogenic properties of expanded cells. Umbilical cord blood CD 34+ cells were effectively expanded (18‐ to 22‐fold) in culture medium containing stem cell factor (SCF), Flt‐3 ligand (Flt‐3), thrombopoietin (TPO) and interleukin‐6 (IL‐6) with (post EX/+VEGF) and without VEGF (post EX/no VEGF). Tube formation in matrigel assay and tissue perfusion/capillary density in mice ischaemic hindlimb were significantly improved by post EX/+VEGF cells compared with fresh CD 34+ and post EX/no VEGF cells. MiR‐210 expression was significantly up‐regulated in post EX/+VEGF cells. MiR‐210 inhibitor abrogated and 210 mimic recapitulated the pro‐angiogenic effects by treatment of post EX/+VEGF and post EX/no VEGF cells respectively. Collectively, these observations highlight a critical role for VEGF in enhancing the angiogenic property of expanded cells, and identify miR‐210 as a potential therapeutic target to enhance CD 34+ stem cell function for the treatment of ischaemic vascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2012.01557.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 76

Metadata

Authors
Alaiti, M. A., Ishikawa, M., Masuda, H., Simon, D. I., Jain, M. K., Asahara, T., & Costa, M. A.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2012-09-26
Volume
16
Issue
10
Pages
2413-2421
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2007486027
Cited by
76
References
3
FWCI
3.60
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Up‐regulation of miR‐210 by vascular endothelial growth factor in ex vivo expanded CD 34+ cells enhances cell‐mediated angiogenesis. https://app.cochat.ai/papers/10.1111/j.1582-4934.2012.01557.x
The paper
Alaiti, M. A., Ishikawa, M., Masuda, H., Simon, D. I., Jain, M. K., Asahara, T., & Costa, M. A. (2012). Up‐regulation of miR‐210 by vascular endothelial growth factor in ex vivo expanded CD 34+ cells enhances cell‐mediated angiogenesis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2012.01557.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.